Dr Reddy's Laboratories shuts all units after cyber attack on servers

Security breach comes days after firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V

Days after Hyderabad-based drug major Dr Reddy’s Laboratories (DRL) received approval from the Indian drug regulator to conduct phase-2 and 3 trials of the Russian Covid-19 vaccine candidate Sputnik V, the company had to shut its plants across the globe after a cyber attack on its servers. 

This is the second such attack on entities conducting vaccine research or trial. 

In July, Chinese hackers stole information from Spanish laboratories working on a Covid-19 vaccine, according to international news agencies. 

Though DRL’s Chief Information Officer Mukesh Rathi said the firm anticipated to restart services within 24 hours, the stock fell by 3 per cent